More medical news from Wall Street Journal
Japanese Institute Fails to Reproduce Stem-Cell Results
Wall Street Journal : December 19, 2014, 12:42 pm
Japan’s Riken research institute said efforts by embattled researcher Haruko Obokata to reproduce results of what was once billed as a groundbreaking method of creating stem cells have failed.
FDA Approves AstraZeneca Ovarian Cancer Drug
Wall Street Journal : December 19, 2014, 8:01 am
The U.S. Food and Drug Administration approved the first drug to treat cases of ovarian cancer linked to specific genetic mutations.
FDA Backs AbbVie's Hepatitis Treatment
Wall Street Journal : December 19, 2014, 6:27 am
U.S. regulators on Friday approved AbbVie’s new multidrug regimen for hepatitis C, and the company priced it below rival treatments from Gilead Sciences.
Life Expectancy Increases by Six Years
Wall Street Journal : December 18, 2014, 12:40 pm
The rise in global life expectancy for men and women by about six years is mainly the result of dramatic advances in health care, according to a study published in the journal Lancet.
Lawsuit Alleges Price Gouging by Maker of Hepatitis Drug
Wall Street Journal : December 18, 2014, 10:50 am
Ever since Gilead Sciences began selling its Sovaldi hepatitis C treatment, there has been controversy over the high price. Last week, the transit agency that serves greater Philadelphia filed an unusual lawsuit claiming that Gilead is price gouging.